Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

NCT: NCT03429582 · COMPLETED

NCT IDNCT03429582
StatusCOMPLETED
Start Date2020-10-30
Completion2025-07-01
SponsorThe Cleveland Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this academic-industrial partnership will be to compare two thermoablation modalities using devices adapted to low and middle income countries (LMICs) to traditional CO2-based cryotherapy for the treatment of cervical precancer. The investigators will investigate whether the cure rates of cervical intraepithelial neoplasia 2 and more severe diagnoses (CIN2+) with these devices are non-inferior compared to that of conventional cryotherapy. The results of this study will affect other research areas by serving as a springboard to exploring treatment alternatives that are amenable to low-resource settings and thus will reach the most vulnerable populations.

Frequently Asked Questions

What is Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device?

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device is a clinical trial registered under NCT03429582. Current status: COMPLETED.

What is the status of NCT03429582?

The current status of NCT03429582 (Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device) is: COMPLETED.

When did Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device start?

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device started on 2020-10-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.